You've probably seen a lot in the media lately about the possibilities of precision medicine powered by personal genomic sequencing. With the advent of the $1000 whole genome sequencing [2], we now have an immense amount of data at our fingertips. The problem we have now is known as the "bioinformatics bottleneck" [3], in which our sequence data reveals thousands of variants in our DNA, and we need to figure out which ones are clinically relevant, by figuring out which ones have been observed and studied. We seek to make that task easy; to minimize the time it takes to perform an exhaustive search, and reduce the chance of missing important information in a patient's sequenced genome [4].
Most people have been or know someone who has been affected by cancer or inheritable disease. As far as missions go, this was an easy one to get behind when I met my co-founder almost five years ago. When my startup at the time got acquired shortly after meeting him, I knew immediately what I wanted to do next.
[1] https://www.genomenon.com/
[2] https://en.wikipedia.org/wiki/$1,000_genome
[3] http://science.sciencemag.org/content/344/6184/653.3
[4] https://scipol.duke.edu/content/questathena-wrongful-death-s...